| 1 |
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball et al. · New England Journal of Medicine
|
3 Aug 2016 |
804 |
| 2 |
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
Carle F. Paul, Jennifer Clay Cather, Melinda Gooderham et al. · British Journal of Dermatology
Open access |
11 Sep 2015 |
485 |
| 3 |
Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Stefan Zeuzem et al. · New England Journal of Medicine
Open access |
25 Jan 2018 |
447 |
| 4 |
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
Xavier Forns, Samuel S. Lee, Joaquin M. Valdes et al. · The Lancet Infectious Diseases
|
15 Aug 2017 |
348 |
| 5 |
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis
Paul Yien Kwo et al. · Journal of Hepatology
Open access |
13 Apr 2017 |
302 |
| 6 |
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Christopher John Edwards, Francisco Javier Blanco, Jeffrey Crowley et al. · Annals of the Rheumatic Diseases
Open access |
20 Jan 2016 |
287 |
| 7 |
Brief Report
Sharon Lynn Walmsley, Axel Baumgarten, Juan Berenguer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Open access |
11 Aug 2015 |
226 |
| 8 |
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment
Fred F Poordad, Franco Felizarta, Armen Asatryan et al. · Hepatology
Open access |
27 Jan 2017 |
203 |
| 9 |
Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Jeffrey Crowley, Diamant Thaçi, P. Joly et al. · Journal of the American Academy of Dermatology
Open access |
14 Apr 2017 |
193 |
| 10 |
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)
Eric Lawitz, Gary Matusow, Edwin DeJesus et al. · Hepatology
Open access |
24 Dec 2015 |
180 |
| 11 |
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)
Phoebe A. Rich, Melinda Gooderham, Hervé Bachelez et al. · Journal of the American Academy of Dermatology
Open access |
10 Nov 2015 |
171 |
| 12 |
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial
Robert S. Brown et al. · Journal of Hepatology
Open access |
2 Nov 2019 |
157 |
| 13 |
Calibrating Environmental DNA Metabarcoding to Conventional Surveys for Measuring Fish Species Richness
Mary E. McElroy, Terra L. Dressler, Georgia Titcomb et al. · Frontiers in Ecology and Evolution
Open access |
28 Aug 2020 |
155 |
| 14 |
Early Tertiary sedimentation in the western Uinta Basin, Utah
Robert T. Ryder, Thomas D. Fouch, JAMES H. ELISON · Geological Society of America Bulletin
|
1976 |
148 |
| 15 |
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
David L. Wyles, Fred F Poordad, Stanley Wang et al. · Hepatology
Open access |
19 Sep 2017 |
147 |
| 16 |
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Bruce E Strober, Jeffrey Crowley, Paul Steven Yamauchi et al. · British Journal of Dermatology
|
17 May 2011 |
146 |
| 17 |
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure
Fred F Poordad, Stanislas Pol, Armen Asatryan et al. · Hepatology
Open access |
20 Nov 2017 |
140 |
| 18 |
Transcriptional Orchestration of the Global Cellular Response of a Model Pennate Diatom to Diel Light Cycling under Iron Limitation
Sarah R. Smith, Jeroen Gillard, Adam B. Kustka et al. · PLoS Genetics
Open access |
14 Dec 2016 |
136 |
| 19 |
Lectures on the Scientific Basis of Medicine
Robert Warren Huntington · American Journal of Clinical Pathology
|
Sep 1956 |
132 |
| 20 |
Involuntary inferior and multidirectional instability of the shoulder: etiology, recognition, and treatment.
J H VARNEY, J K COKER, J J CAWLEY · PubMed
|
1952 |
132 |
| 21 |
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine
Jacob Paul Lalezari, J. Greg Sullivan, Peter Varunok et al. · Journal of Hepatology
Open access |
5 Apr 2015 |
119 |
| 22 |
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
Kim Alexander Papp, Jeffrey Crowley, J.‐P. Ortonne et al. · British Journal of Dermatology
|
16 Nov 2010 |
117 |
| 23 |
Treatment of Nail Psoriasis
Jeffrey Crowley, Jeffrey M Weinberg, Jashin J. Wu et al. · JAMA Dermatology
|
4 Dec 2014 |
100 |
| 24 |
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Boni Elizabeth Elewski, Martin M. Okun, Kim Alexander Papp et al. · Journal of the American Academy of Dermatology
Open access |
12 Oct 2017 |
87 |
| 25 |
Safety of selective IL ‐23p19 inhibitors for the treatment of psoriasis
Jeffrey Crowley, Richard Bruce Warren, Jennifer Cather · Journal of the European Academy of Dermatology and Venereology
Open access |
6 May 2019 |
85 |
| 26 |
Characterization of a Two-Component System Transcriptional Regulator, LtdR, That Impacts Group B Streptococcal Colonization and Disease
Liwen Deng, Rong Mu, Thomas A. Weston et al. · Infection and Immunity
Open access |
23 Apr 2018 |
82 |
| 27 |
One size does not fit all: Toward regional conservation practice guidance to reduce phosphorus loss risk in the Lake Erie watershed
Merrin L. Macrae, Helen P. Jarvie, Roy Brouwer et al. · Journal of Environmental Quality
Open access |
20 Mar 2021 |
79 |
| 28 |
Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
Jeffrey Crowley, Jan R. Mekkes, Christos C. Zouboulis et al. · British Journal of Dermatology
Open access |
19 May 2014 |
78 |
| 29 |
Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
Jennifer Clay Cather, Jeffrey Crowley · American Journal of Clinical Dermatology
Open access |
5 Nov 2014 |
64 |
| 30 |
Load-deflection characteristics of nickel-titanium alloy wires after clinical recycling and dry heat sterilization
Sunil Kapila, John W. Haugen, L.G. Watanabe · American Journal of Orthodontics and Dentofacial Orthopedics
|
Aug 1992 |
59 |
| 31 |
Improving Placement Accuracy in California’s Community Colleges Using Multiple Measures of High School Achievement
Peter Riley Bahr, Loris P. Fagioli, John J. Hetts et al. · Community College Review
Open access |
Apr 2019 |
56 |
| 32 |
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study
C. Leonardi, Jeffrey M. Sobell, Jeffrey Crowley et al. · British Journal of Dermatology
|
7 May 2012 |
52 |
| 33 |
Classification of central amazon lakes on the basis of their microbiological and physico-chemical characteristics
Hakugiat Rai, Gary Hill · Hydrobiologia
|
Jul 1980 |
51 |
| 34 |
The Relational Turbulence Model: A Meta-Analytic Review
Alan K. Goodboy, San Bolkan, Liesel L. Sharabi et al. · Human Communication Research
|
Apr 2020 |
46 |
| 35 |
Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial
Boni Elizabeth Elewski, Christopher Baker, Jeffrey Crowley et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
15 Jul 2019 |
45 |
| 36 |
The Diving and Feeding Activity of the Western Grebe on the Breeding Grounds
George E. Lawrence · Ornithological Applications
|
1950 |
45 |
| 37 |
Impact of Entomopathogenic Fungi on the Growth, Development, and Health of Cabbage Growing under Water Stress
Surendra K. Dara, Sumanth S. R. Dara, Suchitra S. Dara · American Journal of Plant Sciences
Open access |
2017 |
42 |
| 38 |
Efficacy of adalimumab across subgroups of patients with moderate‐to‐severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH
Yves P. Poulin, Jeffrey Crowley, Richard G B Langley et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
22 Jun 2013 |
42 |
| 39 |
?-Lipoic acid-based PPAR? agonists for treating inflammatory skin diseases
MeenakshiS. Venkatraman, Amar Gopal Chittiboyina, Josef G. Meingassner et al. · Archives of Dermatological Research
|
23 Jun 2004 |
41 |
| 40 |
Growth Hormone Alters Brain Morphometry, Connectivity, and Behavior in Subjects with Fatigue after Mild Traumatic Brain Injury
Traver J. Wright, Randall J. Urban, William Durham et al. · Journal of Neurotrauma
Open access |
4 Dec 2019 |
40 |
| 41 |
Selecting Optimum Planting Dates and Plant Populations for Dryland Corn in Kansas
Scott Staggenborg, D. L. Fjell, Daniel L. Devlin et al. · jpa
|
1999 |
39 |
| 42 |
Fumigating `Crimson Seedless' Table Grapes with (E)-2-Hexenal Reduces Mold during Long-term Postharvest Storage
Douglas D. Archbold, Thomas R. Hamilton–Kemp, Ann M. Clements et al. · HortScience
Open access |
Jul 1999 |
38 |
| 43 |
An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19
Cameron Casey Chang, Randolph Senining, Jessica Kim et al. · Journal of Investigative Medicine High Impact Case Reports
Open access |
2020 |
37 |
| 44 |
Functional iron deficiency in hemodialysis patients with high ferritin
Robert C. Kopelman, Lorelei SMITH, Leonard PEOPLES et al. · Hemodialysis International
|
31 Mar 2007 |
37 |
| 45 |
DNA barcoding exposes a case of mistaken identity in the fern horticultural trade
Kathleen M. Pryer, Eric Schuettpelz, Layne Huiet et al. · Molecular Ecology Resources
|
9 Apr 2010 |
36 |
| 46 |
Racism‐Related Stress, General Life Stress, and Psychological Functioning Among Black American Women
Alex L. Pieterse, Robert T. Carter, Kilynda V. Ray · Journal of Multicultural Counseling and Development
|
2013 |
36 |
| 47 |
Scalp psoriasis: an overview of the disease and available therapies.
Jeffrey Crowley · PubMed
|
Aug 2010 |
36 |
| 48 |
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy
Jason Grebely, Gregory J. Dore, Negar Niki Alami et al. · International Journal of Drug Policy
Open access |
5 Feb 2019 |
35 |
| 49 |
Proceedings of the Symposium on Coccidioidomycosis
Robert Warren Huntington · American Journal of Clinical Pathology
|
Oct 1959 |
33 |
| 50 |
Mouth-to-mouth ventilation: The dying art
Anthony Don Michael, James S. Forrester · The American Journal of Emergency Medicine
|
Mar 1992 |
30 |